NASDAQ:KYMR

Kymera Therapeutics Stock Predictions

etoro logo Buy KYMR
*Your capital is at risk
$73.21
+1.92 (+2.69%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

KYMR Prediction Chart

KYMR Predictions History

Latest community submissions for KYMR.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Sep 16, 2022 $29.06 +1.04% $25.91 X 87.84% 0
Sep 16, 2022 Bullish $25.91 X 0
Aug 8, 2022 Bullish $31.43 V 1
Cucumba Cucumba Amateur
May 5, 2022 $24.00 +8.89% $20.02 X 80.12% 0
AlexVel AlexVel Pro
May 5, 2022 $23.31 +5.76% $20.02 X 83.57% 0
JS JS Pro
Jan 11, 2021 $78.76 +2.93% $76.52 X 97.07% 0
DOLLEICLAIRE JOSHI DOLLEICLAIRE JOSHI @DOLLEICLAIREJOSHI.185335
Jan 11, 2021 Bullish $76.52 X 0
JS JS Pro
Dec 14, 2020 $60.53 -9.83% $67.13 X 90.17% 0
Dec 14, 2020 Bearish $67.13 X 0
Deepak Khetan Deepak Khetan @DeepakKhetan.164439
Dec 14, 2020 Bullish $67.13 X 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KYMR with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT KYMERA THERAPEUTICS INC.
Kymera Therapeutics
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, macrophage activation ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE